Published On: 4/3/2019
2019 Women in Business Award!
We would like to congratulate Meg Powell, our Co-Founder and current Board Chair, on her recent recognition by the Triangle Business Journal.
About TARGET PharmaSolutions
Headquartered in Durham, NC, TARGET PharmaSolutions is a privately held real-world data solutions company that provides pharmaceutical and biotechnology partners a more efficient way to generate data in the real-world setting. TARGET PharmaSolutions has six disease communities: TARGET-NASH (nonalcoholic steatohepatitis), TARGET-PBC (primary biliary cholangitis), TARGET-HCC (hepatocellular carcinoma), TARGET-IBD (inflammatory bowel disease), TARGET-DERM (immune mediated skin conditions) and TARGET-HBV (hepatitis B).
For more information, visit www.targetpharmasolutions.com.
984.234.0268 ext 205
03/17/2020TARGET PharmaSolutions Expands TARGET-DERM Research Community with Two New Industry Partnerships
03/13/2020TARGET PharmaSolutions Launches Real-World Asthma Study
02/20/2020TARGET-IBD Poster & Oral Presentation at ECCO
02/13/2020TARGET PharmaSolutions Appoints Neal Bibeau as Chief Executive Officer